Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

isatuximab-irfc

isatuximab-irfc
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Sarclisa INJECTION, INTRAVENOUS 100 mg/5 mL, 500 mg/25 mL      
Comments:

Restricted to use in the oncology outpatient setting. Reimbursement and insurance certification or PAP eligibility required prior to initiation of therapy.

Reviewed: Oct. 2021

Last updated: Nov. 10, 2021






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved